Pelthos Therapeutics Inc. (PTHS) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2022: $100.0K2023: $100.0K2024: $513.0K2025: $17.97M$17.97M
2022Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$17.97M+3403.5%
2024$513.0K+413.0%
2023$100.0K+0.0%
2022$100.0K